Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides

Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides

Sialylated glycolipids, gangliosides play an essential role in the central nervous system regulating recognition and signaling in neurons. Metabolic blocks in processing and catabolism of gangliosides result in development of severe neurological disorders, gangliosidoses manifesting with neurodegene...

Full description

Bibliographic Details
Main Authors:	Pan, X, De Britto Pará De Aragão, C, Velasco-Martin, J, Priestman, D, Wu, H, Takahashi, K, Yamaguchi, K, Sturiale, L, Garozzo, D, Platt, F, Lamarche-Vane, N, Morales, C, Miyagi, T, Pshezhetsky, A
Format:	Journal article
Published:	Federation of American Society of Experimental Biology (FASEB) 2017

Similar Items

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
by: Pshezhetsky, A, et al.
Published: (2017)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
by: Pshezhetsky, A, et al.
Published: (2017)

Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis
by: Somogyi, A, et al.
Published: (2018)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Huebecker, M, et al.
Published: (2019)

An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions
by: Clark, A, et al.
Published: (2021)

Ganglioside antibodies and neuropathies.
by: Rinaldi, S, et al.
Published: (2008)

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
by: Harlalka, G, et al.
Published: (2013)

GM1 ganglioside-independent intoxication by Cholera toxin
by: Cervin, J, et al.
Published: (2018)

Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury.
by: Townson, K, et al.
Published: (2008)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
by: Ranes, M, et al.
Published: (2001)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
by: Baek, R, et al.
Published: (2008)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
by: Baek, R, et al.
Published: (2004)

Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice
by: Baek, R, et al.
Published: (2005)

Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT
by: Pan, X, et al.
Published: (2022)

Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms
by: Viana, GM, et al.
Published: (2020)

Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
by: Viana, GM, et al.
Published: (2020)

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
by: Kasperzyk, J, et al.
Published: (2004)

Dexamethasone: chondroprotective corticosteroid or catabolic killer?
by: Black, Robert Xavier, et al.
Published: (2020)

Studying catabolism of protein ADP-Ribosylation
by: Palazzo, L, et al.
Published: (2017)

Parathyroid hormone - a bone anabolic and catabolic agent.
by: Poole, K, et al.
Published: (2005)

Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
by: Kasperzyk, J, et al.
Published: (2002)

Neuraminidase inhibitors for influenza complications.
by: Del Mar, C, et al.
Published: (2014)

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
by: Kasperzyk, J, et al.
Published: (2004)

Investigating effects of polyamine catabolism on epidermal differentiation
by: Ling, Blysse
Published: (2019)

Catabolic and anabolic phases of osteodystrophy in aged rats.
by: Roach, H, et al.
Published: (2003)

Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors.
by: Chairat, K, et al.
Published: (2012)

Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
by: Chairat, K, et al.
Published: (2013)

TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells
by: Paget, C, et al.
Published: (2019)

Neuraminidase inhibitors for preventing and treating influenza in children
by: Wang, K, et al.
Published: (2012)

Neuraminidase inhibitors for preventing and treating influenza in children.
by: Wang, K, et al.
Published: (2012)

New GM1 Ganglioside Derivatives for Selective Single and Double Labelling of the Natural Glycosphingolipid Skeleton
by: Polyakova, S, et al.
Published: (2009)

Gangliosides play an important role in the organization of CD82-enriched microdomains.
by: Odintsova, E, et al.
Published: (2006)

Gangliosides play a critical role in the organization of the tetraspanin-enriched microdomains
by: Odintsova, E, et al.
Published: (2005)

Histidine catabolism is a major determinant of methotrexate sensitivity
by: Kanarek, Naama, et al.
Published: (2020)

Dynamic regulation of pectin catabolism in the pathogenicity of Dickeya dadantii
by: Debra Ruth David
Published: (2012)

HYDROCARBON CATABOLISM IN CLADOSPORIUM-RESINAE - EFFECT OF HEXADECANE ON SUCCINATE-DEHYDROGENASE ACTIVITY
by: Turner, A, et al.
Published: (1978)

"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
by: Kasperzyk, J, et al.
Published: (2005)

Neuraminidase inhibitors: the story behind the Cochrane review
by: Doshi, Peter
Published: (2009)

Guidelines on neuraminidase inhibitors in children are not supported by evidence.
by: Symmonds, M, et al.
Published: (2004)

Neuraminidase inhibitors for preventing and treating influenza in children.
by: Matheson, N, et al.
Published: (2003)